ArticleJNCI cancer spectrum2022
Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.
Carolyn Horton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it